EX-99.1 2 exhibit99-1.htm PRESS RELEASE OF XILINX, INC. DATED JANUARY 20, 2010 exhibit99-1.htm
Investor Relations Contact:
Lori Owen
Xilinx, Inc.
(408) 879-6911
ir@xilinx.com
Exhibit 99.1
 
XILINX POSTS RECORD SALES OF $513 MILLION
 
SAN JOSE, CA, JANUARY 20, 2010-- Xilinx, Inc. (Nasdaq: XLNX) today announced record third quarter fiscal 2010 sales of $513.3 million, up 24% sequentially and up 12% from the third quarter of the prior fiscal year. Third quarter net income was $106.9 million, or $0.38 per diluted share, including previously announced restructuring charges totaling $5.5 million, or approximately $0.02 per diluted share. On a year over year basis, third quarter net income and diluted earnings per share declined because in the third quarter of fiscal 2009 there was a $58.3 million pre-tax gain from the early extinguishment of convertible debentures, partially offset by a $19.5 million pre-tax impairment charge on investments.
 
The Xilinx Board of Directors announced a quarterly cash dividend of $0.16 per outstanding share of common stock, payable on March 3, 2010 to all stockholders of record at the close of business on February 10, 2010.
 
Additional third quarter comparisons are represented in the charts below:
 
GAAP Results
(In millions, except EPS)
 
Growth Rates
Q3 Q2 Q3
FY 2010       FY 2010       FY 2009       Q-T-Q       Y-T-Y
Net revenues $ 513.3 $ 415.0 $ 458.4 24%   12%
Operating income $ 136.6   $ 82.1   $ 119.6   66%   14%
Net income $ 106.9 $ 64.0 $ 119.4 67%   -10%
Diluted earnings per share $ 0.38 $ 0.23 $ 0.44 65%   -14%

Record sales were driven by strength from all end markets and geographic regions. New Product sales increased 32% sequentially during the quarter due primarily to strong growth from the Virtex®-5 and Spartan®-3 FPGA families.
 
“It was a record-setting quarter for Xilinx,” said Moshe Gavrielov, Xilinx President and Chief Executive Officer. “In addition to record total sales, Xilinx’s Virtex-5 family comfortably surpassed $100 million in quarterly sales—more than any other FPGA product in history. Sales strength from this family was driven by Communications, Industrial and Other and Data Processing. Based on new design win activity, I am confident about the prospects for continued sales growth from the Virtex-5 family.”
 


Net Revenues by Geography:
Percentages Growth Rates
Q3 Q2 Q3
FY 2010       FY 2010       FY 2009       Q-T-Q       Y-T-Y
North America 35%   35%   34%   25%   17%
Asia Pacific 36%   35%   33%   27%   18%
Europe 20%   21% 22%   19%   4%
Japan 9%   9%   11%   17%   -7%

Net Revenues by End Market:
Percentages Growth Rates
Q3 Q2 Q3
FY 2010       FY 2010       FY 2009       Q-T-Q       Y-T-Y
Communications 46%   46%   44%   23%   16%
Industrial & Other 32%   31%   33%   29%   8%
Consumer & Automotive 15%   16%   16%   15%   2%
Data Processing 7%   7%   7%   25%   27%

Net Revenues by Product:
Percentages Growth Rates
Q3 Q2 Q3
FY 2010       FY 2010       FY 2009       Q-T-Q       Y-T-Y
New 33%   31%   21%   32%   72%
Mainstream 33%   33%   34%   22%   9%
Base 29%   31%   40%   18%   -17%
Support 5%   5%   5%   22%   5%

Products are classified as follows:
 
New Products: Virtex-6, Virtex-5, Spartan-6, Spartan-3A and Spartan-3E product families
Mainstream Products: Virtex-4, Spartan-3, Spartan-II and CoolRunner™-II product families
Base Products: Virtex, Virtex-E, Virtex-II, Spartan, XC4000, CoolRunner and XC9500 product families
Support Products: Configuration products, HardWire, Software & Support/Services
 
Key Statistics:
(Dollars in millions)
 
Q3 Q2 Q3 
FY 2010       FY 2010       FY 2009
Annual Return on Equity (%)* 14 10 20
Operating Cash Flow $185   $118   $128
Depreciation Expense $13   $12   $13
Capital Expenditures $9   $4   $11
Combined Inventory Days 85 75 99
Revenue Turns (%) 58 57 54

*     Return on equity calculation: Annualized net income/average stockholders’ equity
 
2
 


Product and Financial Highlights
 
     
Ø
      Building upon Virtex-5 success, Xilinx today announced that its Virtex-6 family has achieved full production qualification and is commencing volume shipments. Xilinx also recently announced first shipments and availability of the industry’s largest FPGA, the 40-nm LX760, which is ideal for use in advanced prototyping platforms and the ASIC emulation market.
   
Ø
On October 19, 2009, Xilinx and ARM announced they are collaborating to enable ARM processor and interconnect technology on Xilinx FPGA products. This agreement is expected to allow programmable solutions to penetrate even deeper into existing markets and expand into new market spaces by leveraging ARM’s processor strengths and ecosystem.
 
Ø
On December 8, 2009, Xilinx announced six new Targeted Design Platform development kits for the Virtex-6 and Spartan-6 product families. The new kits increase productivity and innovation for electronic designers in the areas of target embedded processing, DSP and high speed serial connectivity.
   
Ø
December quarter operating margin was 27%, up from 20% in the prior quarter and the highest reported by the Company in four years. Improved customer demand and continued spending discipline contributed to the operating margin increase.
 
Business Outlook – March Quarter Fiscal 2010
 
     
Ø
      Sales are expected to be up 3% sequentially to down 1% sequentially.
Ø
Gross margin is expected to be approximately 64% to 65%.
Ø
Operating expenses are expected to be approximately $180 million, including $3 million in previously announced restructuring charges.
Ø
Other income and expense is expected to be a net expense of approximately $2 million.
Ø
Fully diluted share count is expected to be approximately 275 million.
Ø
March quarter tax rate is expected to be approximately 20%.
 
Conference Call
 
A conference call will be held today at 2:00 p.m. Pacific Time to discuss the quarter's results and management's outlook for the March quarter. The webcast and subsequent replay will be available in the investor relations section of the company's web site at www.investor.xilinx.com. A telephonic replay of the call may be accessed later in the day by calling (800) 642-1687 and referencing confirmation code 47787165. The telephonic replay will be available for two weeks following the live call.
 
3
 


This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as “expect,” “may,” “will,” “could,” “believe,” “anticipate,” “estimate,” “continue,” “plan,” “intend,” “project” or other similar words. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including the general health of global economies as well as of the semiconductor industry, the health of our end markets and our customers' customers, the ability of our foundry suppliers to deliver sufficient wafer volumes in a timely manner, our ability to forecast end customer demand, customer acceptance of our new products, the ability of the Company to generate cost and operating expense savings in an efficient and timely fashion, the ability of our customers to manage their inventories, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, and other risk factors listed in our most recent Forms 10-K and 10-Q.
 
About Xilinx
 
Xilinx, Inc. (NASDAQ: XLNX) is the worldwide leader of programmable logic solutions. Additional information about Xilinx is available at http://www.xilinx.com. Xilinx, the Xilinx logo, Virtex, Spartan, ISE, and other brands designated herein are trademarks of Xilinx in the United States and other countries. All other trademarks are the property of their respective owners.
#1004F
 
4
 


XILINX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share amounts)
 
Three Months Ended Nine Months Ended
     Jan. 2,      Dec. 27,      Sept. 26,      Jan. 2,      Dec. 27,
2010 2008* 2009 2010 2008*
Net revenues $   513,349 $   458,387 $   414,950 $   1,304,534 $   1,430,170
Cost of revenues 184,320 165,331 158,177 486,319 519,244
Gross margin 329,029 293,056 256,773 818,215 910,926
Operating expenses:
       Research and development 101,867 86,967 90,145 275,245 267,202
       Selling, general and administrative 85,037 85,032 78,621 237,214 266,116
       Amortization of acquisition-related intangibles 1,475 2,493 4,326
       Restructuring charges 5,531 5,915 27,217 22,023
              Total operating expenses 192,435 173,474 174,681 542,169 559,667
 
Operating income 136,594 119,582 82,092 276,046 351,259
Impairment loss on investments (3,041 ) (19,540 ) (3,041 ) (53,162 )
Gain on early extinguishment of convertible debentures   58,290   58,290
Interest and other income (expense), net   (542 )   (1,743 ) (1,782 ) (13,234 ) 9,975
Income before income taxes 133,011   156,589     80,310   259,771 366,362
Provision for income taxes 26,103 37,145   16,272 50,819   82,680
Net income $ 106,908 $ 119,444 $ 64,038 $ 208,952   $ 283,682
 
Net income per common share:
       Basic $ 0.39 $ 0.44 $ 0.23 $ 0.76 $ 1.03
       Diluted $ 0.38 $ 0.44 $ 0.23 $ 0.75 $ 1.02
Cash dividends declared per common share $ 0.16 $ 0.14 $ 0.14 $ 0.44 $ 0.42
Shares used in per share calculations:
       Basic 276,832 273,997 276,353 275,989 276,584
       Diluted 278,566 274,223 276,988 277,030 277,603
 

*       As adjusted due to the retrospective adoption of the accounting standard for convertible debentures in the first quarter of fiscal 2010.



XILINX, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
 
  Jan. 2,         March 28,
  2010 2009*
  (Unaudited)  
ASSETS      
Current assets:      
       Cash, cash equivalents and short-term investments $    1,489,993 $    1,324,933
       Accounts receivable, net   231,078   216,390
       Inventories   128,935   119,832
       Deferred tax assets and other current assets   108,720   91,313
Total current assets   1,958,726   1,752,468
Net property, plant and equipment   367,514   387,907
Long-term investments   503,106   347,787
Other assets   292,605   323,739
Total Assets $ 3,121,951 $ 2,811,901
         
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities:      
       Accounts payable and accrued liabilities $ 284,573 $ 170,702
       Deferred income on shipments to distributors   77,395   62,364
Total current liabilities   361,968   233,066
Convertible debentures   354,460   352,110
Deferred tax liabilities   247,822   196,189
Other long-term liabilities   123,793     81,776
Stockholders' equity   2,033,908   1,948,760
Total Liabilities and Stockholders' Equity $ 3,121,951 $ 2,811,901

*       Derived from audited financial statements and adjusted for the retrospective adoption of the accounting standard for convertible debentures in the first quarter of fiscal 2010.
  


XILINX, INC.
SUPPLEMENTAL FINANCIAL INFORMATION
(Unaudited)
(In thousands)
 
  Three Months Ended Nine Months Ended
  Jan. 2,         Dec. 27,         Sept. 26,         Jan. 2,         Dec. 27,
2010 2008* 2009 2010 2008*
SELECTED CASH FLOW INFORMATION:            
       Depreciation $   12,867   $   13,438   $   12,056   $   37,932   $   42,167  
       Amortization 3,210   4,069     3,260   11,777   12,420  
       Stock-based compensation 15,519   13,041     11,762   41,010   41,188  
       Net cash provided by operating activities 185,478   128,479     117,976   450,421   381,676  
       Purchases of property, plant and equipment (8,693 ) (11,061 )   (4,133 ) (17,540 ) (32,711 )
       Payment of dividends to stockholders (44,299 ) (38,357 )   (38,744 ) (121,617 ) (115,982 )
       Repurchases of common stock (25,000 )       (25,000 ) (275,000 )
       Proceeds from issuance of common stock                      
              to employees and excess tax benefit   13,546       2,992       15,677       13,167       84,379  
 
STOCK-BASED COMPENSATION INCLUDED IN:            
       Cost of revenues $ 1,291   $ 1,337   $ 1,272   $ 3,678     $ 4,416  
       Research and development 7,289     6,055       5,205       18,140   18,702  
       Selling, general and administrative   6,939     5,649     5,285   18,247   17,506  
       Restructuring charges         945     564  

*       As adjusted due to the retrospective adoption of the accounting standard for convertible debentures in the first quarter of fiscal 2010